25 results returned.
Page   of  2

Pharmaceutical Care Management Association (PCMA) v. Mulready
District Court: District Court of Western District of Oklahoma    Status: Pending
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans …
State of Ohio v. OptumRx
District Court: Ohio Court of Common Pleas (Franklin County)    Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass …
Minnesota v. Sanofi-Aventis U.S. LLC
District Court: District Court of New Jersey    Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Pharm. Care Mgmt. Ass’n v. Tufte
District Court: District of North Dakota    Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act …
Pharm. Care Mgmt. Ass’n v. Gerhart
District Court: Southern District of Iowa    Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing …
Federal Trade Commission v. Allergan and Watson Laboratories, Inc. et al.
District Court: Northern District of California    Status: Decided
On January 23, 2017, the FTC refiled a complaint against Watson Laboratories and its former parent company, Allergan, for entering a pay-for-delay settlement with EndoPharmaceuticals to block a generic version of …
Federal Trade Commission v. Actavis, Inc.
District Court: Northern District of Georgia    Status: Decided
The Supreme Court ruled in favor of the FTC, holding that a brand name manufacturer’s payment to a generic competitor to settle patent infringement claims …
Federal Trade Commission v. Shire ViroPharma Inc.
District Court: District of Delaware    Status: Decided
On February 7, 2017, the FTC filed a complaint against Shire ViroPharma, alleging that the pharmaceutical company engaged in unfair method of competition and violated …
Negron v. Cigna and OptumRx
District Court: District of Connecticut    Status: Pending
Cigna faces a class-action lawsuit alleging the insurance giant overcharged its members by more than 10 times the amount the insurer paid for certain prescription …
Shire US, Inc. v. Allergan, Inc. et al.
District Court: District of New Jersey    Status: Pending
On October 2, 2017, Shire filed a complaint in New Jersey district court accusing Allergan of violating federal and state antitrust laws by improperly discounting …
In Re UnitedHealth Group PBM Litigation
District Court: District of Minnesota    Status: Decided
Plan members brought suit against UnitedHealth Group, Inc. under ERISA and RICO for Defendants’ conduct in administrating pharmacy benefits that allegedly caused Plaintiffs to overpay …
In re: Suboxone Antitrust Litigation (State of Wisconsin, et al. v. Indivior Inc, et al.)
District Court: E.D. Pennsylvania    Status: Pending
In September 2016, 35 state attorneys general and the District of Columbia brought a multi-district case against pharmaceutical manufacturer Indivior, MonoSol RX et al.,  alleging …
Mohr-Lercara v. Oxford Health Ins., Inc.
District Court: Southern District of New York    Status: Pending
A proposed class action was filed in New York federal court accusing Oxford Health Insurance of overcharging patients for prescription drugs. The complaint alleges that …
RxStrategies v. CVS Pharmacy
District Court: M.D. Florida    Status: Pending
340B administrator RxStrategies sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as a “must …
In re: Flonase Antitrust Litigation
District Court: Eastern District of Pennsylvania    Status: Pending
On December 22, 2017, the U.S. Court of Appeals for the Third Circuit ruled that an antitrust suit filed by Louisiana’s Attorney General against GlaxoSmithKline …
Sentry Data Sys. v. CVS Health
District Court: S.D. Florida    Status: Pending
340B administrator Sentry Data Systems sued CVS pharmacy alleging that since CVS aquired Wellpartner, the company has engaged in unlawful tying, using its status as …
25 results returned.
Page   of  2